H.C. Wainwright initiated coverage on LENZ Therapeutics with a new price target

8/12/24 7:41:11 AM ET

Biotechnology: Biological Products (No Diagnostic Substances)

Health Care

H.C. Wainwright initiated coverage of LENZ Therapeutics with a rating of Buy and set a new price target of $38.00

Save time and jump to the most important pieces.

Recent Analyst Ratings for
$LENZ

Date	Price Target	Rating	Analyst
4/14/2025	$38.00 → $51.00	Overweight	Piper Sandler
3/18/2025	$60.00	Buy	TD Cowen
9/27/2024	$37.00	Outperform	Raymond James
8/12/2024	$38.00	Buy	H.C. Wainwright
4/15/2024		Outperform	William Blair
4/15/2024	$32.00	Outperform	Leerink Partners
4/10/2024	$34.00	Buy	Citigroup
3/27/2024	$28.00	Overweight	Piper Sandler